Schedule 13D - Activist Investments
SCHEDULE 13D/A: Major Shareholder James Mellon Boosts Stake in Portage Biotech Through Private Offering
James Mellon, a significant investor, has increased his beneficial ownership in Portage Biotech Inc. to 16.7% by acquiring an additional 121,951 ordinary shares in a private offering at $4.10 per share, providing operating capital to the company.
Capital raise
Better than expected
SCHEDULE 13D/A: Major Shareholder Gregory Bailey Boosts Stake in Portage Biotech, Providing Operating Capital
Gregory H. Bailey, a significant shareholder, increased his beneficial ownership in Portage Biotech Inc. to 30.7% through a private placement, providing operating capital to the company.
Capital raise
Schedule 13G - Passive Investments
Kendall Brazos Duncan has filed a Schedule 13G, reporting beneficial ownership of 1,172,600 ordinary shares, representing 5.3% of the class, in Alpha Compute Corp.
Jane Street Group, LLC, Jane Street Capital, LLC, and Jane Street Global Trading, LLC have collectively reported beneficial ownership of 5.6% of Alpha Compute Corp's ordinary shares.
Orca Capital AG has reported a 9.9% beneficial ownership stake in AlphaTON Capital Corp, holding 1,410,000 ordinary shares.
Capital raise
Better than expected